Cell and Gene Therapy CRO Market Size, Demand and Trends Analysis 2035
Projections indicate that, cell and gene therapy CRO industry is projected to rise from USD 5.39 billion in 2025 to USD 12.59 billion by 2034, reflecting a CAGR of 9.9% over the next decade. The cell and gene therapy CRO market is growing as CROs work with cell and gene therapies targeting a wide array of diseases, cancer, rare and inherited genetic disorders, neurodegenerative and degenerative diseases, and immunological and infectious diseases. North America is dominant in the market due strong biotechnology ecosystem and robust funding from the government.
Last Updated : 09 September 2026
Category: Cell and Gene
Insight Code: 6095
Format: PDF / PPT / Excel